Clinical Trial Update: A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of PT027 compared with PT007 in symptomatic Chinese adults with asthma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PT007
• PT027

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: RECRUITING